Drawing for CLEARRX

USPTO serial 99548617

CLEARRX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
REID, CAILE MAUREEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with CLEARRX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan A LaVine

Jordan A LaVine FLASTER GREENBERG PC100 Front Street, Suite 100Conshohocken, PA 19428United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for use in automating clinical and administrative workflows, evaluating treatment-related eligibility, identifying therapy-related affordability comparisons, transmitting electronic communications, and providing technology-enabled tools that support coordination of patient access to care; all of the foregoing being directed to doctors and healthcare providers, and none of the foregoing involving retail pharmacy services, pharmacy benefit management services, prescription drug plan administration, claims adjudication, electronic patient monitoring, remote physiologic monitoring, medical diagnosis, or clinical decision-makingACTIVE—
042Providing temporary use of on-line non-downloadable software for use in automating clinical and administrative workflows, evaluating treatment-related eligibility, identifying therapy-related affordability comparisons, transmitting electronic communications, and enabling technology-enabled tools that support coordination of patient access to care; all of the foregoing being directed to doctors and healthcare providers, and none of the foregoing involving retail pharmacy services, pharmacy benefit management services, prescription drug plan administration, claims adjudication, electronic patient monitoring, remote physiologic monitoring, medical diagnosis, or clinical decision-makingACTIVE—
045Prescription clearinghouse services, namely, managing medications in the nature of providing patient advocate and case management services and coordinating the procurement and administration of medication; all of the foregoing being directed to doctors and healthcare providers, and none of the foregoing involving retail pharmacy services, pharmacy benefit management services, prescription drug plan administration, electronic patient monitoring, remote physiologic monitoring, medical diagnosis, or clinical decision-makingACTIVEOct 7, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 25, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 25, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 19, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 30, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 18, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 18, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 18, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 28, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2026DOCKASSIGNED TO EXAMINER—
Dec 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance